WHO Launches $518m Ebola Response Plan as Uganda Death Toll Climbs

June 9, 2026 4 min read

The World Health Organisation and the Africa Centres for Disease Control and Prevention launched a $518 million emergency Ebola response strategy on Thursday, as Uganda struggles to contain an outbreak that has pushed the death toll to 55. The joint plan, announced in Geneva and Addis Ababa, outlines coordinated vaccination drives, border screening upgrades, and laboratory capacity improvements across East Africa. Officials warned that without swift international backing, the virus could spread beyond Uganda's borders within weeks.

The $518 Million Emergency Package

The bulk of the funding will finance the deployment of two WHO-approved vaccines, with 100,000 doses earmarked for high-risk districts in Uganda's western region. An additional $85 million has been allocated to strengthen contact-tracing networks across six East African nations that share porous borders with Uganda.

Dr Matshidiso Moeti, WHO's Africa director, confirmed in a statement that the organisation had activated its Contingency Fund for Emergencies. "We are moving faster than we did during previous outbreaks," she wrote. The Africa CDC, meanwhile, said it would deploy 200 epidemiologists to support Uganda's Ministry of Health in Kampala.

Uganda's Worsening Situation

Uganda declared the Ebola outbreak in September, identifying the Sudan strain of the virus in the district of Mubende. Since then, cases have been reported in at least seven districts, including the capital Kampala. Health authorities in Uganda confirmed 55 deaths as of Thursday, with 141 confirmed infections.

The outbreak has strained an already fragile healthcare system. Local media reported that three hospitals in affected districts have suspended non-emergency services to handle Ebola cases. Community resistance to contact-tracing teams has also hampered response efforts in rural areas, according to the Uganda Red Cross.

Border Towns on High Alert

Townships along Uganda's western border with the Democratic Republic of Congo have erected informal screening checkpoints. Traders crossing daily between Fort Portal and DRC territory described long delays. The DRC itself has not reported cases linked to the Uganda outbreak, but officials in Kinshasa said they were monitoring the situation closely.

Economic Ripples Across East Africa

Uganda's tourism sector, which accounts for roughly 8 percent of GDP, is already feeling the impact. Booking cancellations at lodges near national parks in the western region began rising in October, industry representatives said. The Uganda Tourism Association warned that a prolonged outbreak could cost the sector $200 million in lost revenue.

Cross-border trade with Kenya and South Sudan has slowed at the Elegu and Busia crossings. Freight drivers reported delays of up to six hours as border health officials implemented new screening protocols. The East African Business Council called for harmonised testing procedures to avoid disruptions to regional supply chains.

Investor Concerns and Market Sentiment

The announcement of the $518 million response plan brought limited relief to financial markets. Uganda's shilling weakened by 1.2 percent against the dollar in early Thursday trading before recovering, according to data from the Bank of Uganda. Analysts at Stanbic Bank Uganda noted that investor confidence remained fragile pending clarity on the outbreak's trajectory.

Regional stock markets showed mixed reactions. The Nairobi Securities Exchange slipped 0.8 percent on Wednesday before stabilising. South African investors with exposure to East African markets said they were monitoring the situation but had not begun repositioning portfolios. "Health crises of this nature create uncertainty, but the economic impact depends entirely on containment speed," said an analyst at RMB Uganda.

Vaccine Development and Pharmaceutical Interest

Two vaccines are central to the WHO strategy. The Johnson & Johnson single-dose shot, previously used in the DRC, and a new formulation from the Sabin Vaccine Institute are both included in the rollout plan. WHO officials said clinical data from trials in Uganda would be reviewed by December.

Pharmaceutical manufacturers have taken note. Analysts tracking the sector said successful containment could open doors for broader vaccine stockpiling agreements across African markets. The Africa CDC has been in discussions with at least three vaccine makers about regional manufacturing partnerships, though no deals have been finalised.

International Response and Funding Gaps

The $518 million target represents a significant sum, but donors have been slow to commit. As of Thursday, the WHO had received binding pledges of $120 million, leaving a funding gap of nearly $400 million. The United States Agency for International Development said it was reviewing its contribution. The European Commission's health emergency authority confirmed a preliminary pledge of €15 million.

African Union members have been urged to contribute through the Africa Volunteer Health Corps. South Africa's health ministry said it had offered to send a 12-person specialist team to support operations in Kampala, pending cabinet approval.

What Happens Next

WHO officials said the next two weeks would be decisive. If case numbers stabilise in the current hotspot districts, the outbreak could be contained by February, according to modelling published by the London School of Hygiene and Tropical Medicine. If transmission spreads to Kampala's densely populated areas, the timeline extends to mid-year and the financial burden could exceed the current $518 million estimate.

Donor conferences are scheduled for December and January. Uganda's government will present its own domestic response budget to parliament next week. For investors and businesses operating in East Africa, the coming fortnight offers the clearest signal yet of whether this outbreak becomes a regional economic disruption or a contained health emergency.